preloader

About author

James Larkin

James is CEO and co-founder of Oxomics. Contact James using the email link below.


Author's posts

Landmark cancer detection paper published

Wednesday, Jan 5, 2022

Today we published our study in Clinical Cancer Research outlining how our new blood test can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body.

Read more

Oxomics wins Oxford AHSN accelerator

Thursday, Dec 9, 2021

Oxomics are very pleased to announce that they’ve been selected as the overall winner of the 2021 Oxford AHSN Accelerator, receiving £50,000 worth of business support from WAPG.

Read more